Discovery of XL413, a potent and selective CDC7 inhibitor
Elena S. Koltun(Exelixis (United States)), Amy Lew Tsuhako(Exelixis (United States)), David S. Brown(Exelixis (United States)), Naing Aay(Exelixis (United States)), Arlyn Arcalas(Exelixis (United States)), Vicky Chan(Exelixis (United States)), Hongwang Du(Exelixis (United States)), Stefan Engst(Exelixis (United States)), Kim Ferguson(Exelixis (United States)), Maurizio Franzini(Exelixis (United States)), Adam Galan(Exelixis (United States)), Charles R. Holst(Exelixis (United States)), Ping Huang(Exelixis (United States)), Brian Kane(Exelixis (United States)), Moon H. Kim(Exelixis (United States)), Jia Li(Exelixis (United States)), David W. Markby(Exelixis (United States)), Manisha Mohan(Exelixis (United States)), Kevin Noson(Exelixis (United States)), Arthur Plonowski(Exelixis (United States)), Steven J. Richards(Exelixis (United States)), Scott Robertson(Exelixis (United States)), Kenneth J. Shaw(Exelixis (United States)), Gordon M. Stott(Exelixis (United States)), Thomas J. Stout(Exelixis (United States)), Jenny Young(Exelixis (United States)), Peiwen Yu(Exelixis (United States)), Cristiana A. Zaharia(Exelixis (United States)), Wentao Zhang(Exelixis (United States)), Peiwen Zhou(Exelixis (United States)), John M. Nuss(Exelixis (United States)), Wei Xu(Exelixis (United States)), Patrick C. Kearney(Exelixis (United States))
Cited by 91Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis